Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
START Los Angeles, Los Angeles, California START Midwest, Grand Rapids, Michigan START New York, Lake Success, New York Next Oncology - Austin, Austin, Texas Next Oncology - Houston, Houston, Texas Next Oncology - Dallas, Irving, Texas START San Antonio, San Antonio, Texas START Mountain Region, West Valley City, Utah